Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Bright Peak Therapeutics AG”

3 pharma patents match "Bright Peak Therapeutics AG" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "Bright Peak Therapeutics AG" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “Bright Peak Therapeutics AG” · 30,257 patents in full index Clear search

  1. US 12383631

    Immune antigen specific IL-18 immunocytokines and uses thereof

    Bright Peak Therapeutics AG · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted

  2. US 12173062

    Modified TNF-α antibodies and uses thereof

    Bright Peak Therapeutics AG · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted

  3. US 11633488

    Modified IL-2 polypeptides and uses thereof

    Bright Peak Therapeutics AG · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.